Dr. Brian G.M. Durie (1942-2025) was a co-founder of the International Myeloma Foundation and a Hematologist/Oncologist specializing in multiple myeloma and related disorders at the Cedars-Sinai Medical Center in Los Angeles. He was former Medical Director of Myeloma Research for the Academic Myeloma Consortium and co-chairman of the myeloma committee for the SWOG Cancer Research Network. Previously, he was a professor at the University of Arizona, College of Medicine, and the Charing Cross and Westminster School of Medicine at the University of London. 

Dr. Durie is known for his notable research on multiple myeloma and blood disorders, most especially for developing the Durie-Salmon Staging System. 

One of his key BSRI® projects, iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) is the first large-scale screening study in the field of myeloma aimed at preventing myeloma before it develops. His other key projects included the i2TEAMM (International Independent Team for Endpoint Approval of Myeloma MRD) Initiative and the BSRI® ASCENT Cure Trial.  

Dr. Durie received numerous accolades for his outstanding contributions in the field of myeloma: an Honorary Doctor of Medicine award from the Vrije Universteit Brussel in 2019, the Waldenström's Award in 2009, and the Robert A. Kyle Lifetime Achievement Award in 2006. He is also a Leukemia Society of America Scholar and a U.S. Hematologic Research Foundation Annual Awardee. 

He wrote over 700 research papers, 16 book chapters, and 5 books. He also held an international patent for scintillation autoradiography.

Dr. Durie was actively involved in global congress events in Europe, which included the annual Heidelberg Myeloma Workshop and annual conferences hosted by the Eurasian Hematology-Oncology Group. 

He produced over 200 videos for his weekly series, “Ask Dr. Durie,” where he addressed patient questions about multiple myeloma and provides information on the latest developments in myeloma treatments. Complementing the video series was his weekly blog, where he also featured highlights of annual events including the ASH Educational Program, IMWG Summit, AMN Summit, GMAN Summit, and the Support Group Leaders Summit.  

Dr. Durie hosted hundreds of IMF Patient & Family Webinars and Regional Community Workshops, providing up-to-date and direct information from leading myeloma experts to myeloma patients and their families.    

Born in Scotland, Dr. Durie received his medical degree from the University of Edinburgh Medical School. He completed residencies and fellowships at Mayo Clinic and the University of Minnesota. He was board certified by the American Board of Internal Medicine with subspecialties in both medical oncology and hematology.

Dr. Durie passed away on October 12, 2025 at age 82. He leaves behind a remarkable and enduring legacy for fellow researchers and clinicians to emulate, as the search for a cure continues. Visit this tribute page honoring Dr. Durie's legacy.